'Thrombin generation' presentation slideshows

Bleeding Diathesis Inherited & Acquired Causes of Bleeding Disorders

Harry Kopolovich. Bleeding Diathesis Inherited & Acquired Causes of Bleeding Disorders. Clinical Vignette #1. 24 y/o male with a history of Hemophilia A is playing baseball, when a line drive strikes him in the head

1.04k views • 62 slides

CIRRHOSIS

PORTAL VEIN THROMBOSIS; ANTICOAGULANT ?YES AND NO Dr. MOHAMMED EMAM Prof. tropical medicine and Hepatology ZAGAZIG UNIVERSITY 2011. CIRRHOSIS.

575 views • 49 slides

Haemostasis in Trauma- Role of Viscoelastic Haemostatic Assay

Haemostasis in Trauma- Role of Viscoelastic Haemostatic Assay. Joint hospital surgical grand round 14 April 2018 Dr. Wong Cheuk Wah Queen Elizabeth Hospital. https://image.slidesharecdn.com/1-150412163625-conversion-gate01/95/1-primeira-apresentao-rx-do-trauma-2-638.jpg?cb=1428874665.

375 views • 35 slides

Does BICARBONATE Correct Coagulation Function impaired by Acidosis in Swine ?

393 views • 32 slides

Crit Care Med 2006 March Vol.34 p871-877 Ri ???

460 views • 30 slides

Hemostasis, platelets and Blood management

Julie Wegner, PhD, CP Midwestern University Glendale, AZ. Hemostasis, platelets and Blood management. Disclosure. None. Why do patients bleed?. Macrovascular Microvascular Inability to generate thrombin Insufficient clotting surface (platelets)

437 views • 26 slides

The classical dose range is reported between 20 and 70 IU/kg/h.

Systemic anticoagulation during ECMO is intended to control thrombin generation and limit the risk for thrombotic and hemorrhagic complications. Unfractionated heparin (UFH) is the most commonly used anticoagulant. UFH acts by binding and inactivating factor Xa and thrombin.

174 views • 17 slides

Dr Diana A Gorog Consultant Cardiologist & Honorary Clinical Senior Lecturer

Presented at. Measurement of Clopidogrel Resistance by ADP-Inhibition Does Not Reflect the Benefit of Clopidogrel on Overall Thrombotic Status. Dr Diana A Gorog Consultant Cardiologist & Honorary Clinical Senior Lecturer E & N Hertfordshire NHS Trust & Imperial College, London, UK.

265 views • 15 slides

Change in thrombin generation following edoxaban 60 mg once-daily in healthy subjects

Change in thrombin generation following edoxaban 60 mg once-daily in healthy subjects. 40. 20. 0. -20. % change from baseline, thrombin peak. -40. -60. -80. -100. 36. 48. 60. 0. 12. 24. 72. Time (hours post-dose). Lip and Agnelli. Eur Heart J. 2014 .

216 views • 1 slides

Change in thrombin generation following edoxaban 60 mg once-daily in healthy subjects

40. Change in thrombin generation following edoxaban 60 mg once-daily in healthy subjects. 20. 0. -20. % change from baseline, thrombin peak. -40. -60. -80. -100. 36. 48. 60. 0. 12. 24. 72. Time (hours post-dose). Lip and Agnelli. Eur Heart J. 2014.

187 views • 1 slides

Thrombin generation in two families with MYH-9-related platelet disorder

Thrombin generation in two families with MYH-9-related platelet disorder. Eva Zetterberg, MD, PhD 1 , Margareta S Carlsson Alle , MD, PhD 2, Jari Nivala , MD 3 , Juliane Najm , PhD 4 , Andreas Greinacher , MD 5

96 views • 1 slides